Literature DB >> 23602163

Human rabies: neuropathogenesis, diagnosis, and management.

Thiravat Hemachudha1, Gabriella Ugolini, Supaporn Wacharapluesadee, Witaya Sungkarat, Shanop Shuangshoti, Jiraporn Laothamatas.   

Abstract

Rabies is an almost invariably fatal disease that can present as classic furious rabies or paralytic rabies. Recovery has been reported in only a few patients, most of whom were infected with bat rabies virus variants, and has been associated with promptness of host immune response and spontaneous (immune) virus clearance. Viral mechanisms that have evolved to minimise damage to the CNS but enable the virus to spread might explain why survivors have overall good functional recovery. The shorter survival of patients with furious rabies compared with those with paralytic rabies closely corresponds to the greater amount of virus and lower immune response in the CNS of patients with the furious form. Rabies virus is present in the CNS long before symptom onset: subclinical anterior horn cell dysfunction and abnormal brain MRI in patients with furious rabies are evident days before brain symptoms develop. How the virus produces its devastating effects and how it selectively impairs behaviour in patients with furious rabies and the peripheral nerves of patients with paralytic rabies is beginning to be understood. However, to develop a pragmatic treatment strategy, a thorough understanding of the neuropathogenetic mechanisms is needed.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23602163     DOI: 10.1016/S1474-4422(13)70038-3

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  91 in total

1.  Case Reports: Survival from Rabies: Case Series from India.

Authors:  Reeta S Mani; Tina Damodar; Divyashree S; Srikanth Domala; Birendra Gurung; Vilas Jadhav; Ramesh Konanki; Lokesh Lingappa; Sathish Kumar Loganathan; Rajendra Salagare; Priyash Tambi
Journal:  Am J Trop Med Hyg       Date:  2019-01       Impact factor: 2.345

2.  Rabies in travelers.

Authors:  Philippe Gautret; Philippe Parola
Journal:  Curr Infect Dis Rep       Date:  2014-03       Impact factor: 3.725

3.  Peripheral nervous system manifestations of infectious diseases.

Authors:  Kate T Brizzi; Jennifer L Lyons
Journal:  Neurohospitalist       Date:  2014-10

4.  [Vaccinations for international travelers].

Authors:  N Berens-Riha; M Alberer; T Löscher
Journal:  Internist (Berl)       Date:  2014-03       Impact factor: 0.743

Review 5.  Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.

Authors:  Tim K Mackey; Bryan A Liang; Raphael Cuomo; Ryan Hafen; Kimberly C Brouwer; Daniel E Lee
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

6.  Rabies encephalitis presenting with new-onset refractory status epilepticus-Update.

Authors:  Mauricio F Villamar; Vanessa D Smith; Jonathan H Smith; Dianne Wilson; Gerard J Nuovo
Journal:  Neurol Clin Pract       Date:  2020-02

7.  Severe ketoalkalosis as initial presentation of imported human rabies in France.

Authors:  Damien Contou; Laurent Dacheux; Inès Bendib; Sarah Jolivet; Christophe Rodriguez; Françoise Tomberli; Laurent Cleret de Langavant; Rachel Lavenir; Anthony Lepelletier; Florence Larrous; Cécile Troupin; Hervé Bourhy; Christian Brun-Buisson
Journal:  J Clin Microbiol       Date:  2015-04-08       Impact factor: 5.948

8.  Injecting rabies immunoglobulin (RIG) into wounds only: A significant saving of lives and costly RIG.

Authors:  Omesh Kumar Bharti; Shampur Narayan Madhusudana; Henry Wilde
Journal:  Hum Vaccin Immunother       Date:  2017-02-22       Impact factor: 3.452

9.  Rabies encephalitis presenting with new-onset refractory status epilepticus (NORSE).

Authors:  Mauricio F Villamar; Jonathan H Smith; Dianne Wilson; Vanessa D Smith
Journal:  Neurol Clin Pract       Date:  2017-10

10.  Establishment of a longitudinal pre-clinical model of lyssavirus infection.

Authors:  Kate E Mastraccio; Celeste Huaman; David Warrilow; Greg A Smith; Scott B Craig; Dawn L Weir; Eric D Laing; Ina L Smith; Christopher C Broder; Brian C Schaefer
Journal:  J Virol Methods       Date:  2020-05-12       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.